Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198965 · ClinicalTrials.gov registry record · NA
Olestra Containing Foods and Weight Loss and Weight Maintenance
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT00198965 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 257 participants.
The verdict
NCT00198965, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
This study will be conducted over three phases. Phase I will be a 16-week weight lass phase. Phase II will be a 52-week maintenance phase. Phase III will be a follow-up phase. We will test three diet regimens: 1) an olestra group who will receive a weight-reducing diet that includes olestra-containing products; 2) a triglyceride group who will receive the same weight-reducing diet but with foods made with triglyceride (regular fat); 3) a low-fat group will be instructed to consume a diet made of traditionally low-fat foods that ate available in grocery stores (no olestra foods). These groups will be re-randomized for the maintenance phase and again assigned to one of the three weight loss regimens described above: olestra, triglyceride, or low-fat. In the double-blinded experimental design, groups receiving olestra foods will not be informed of the nutrient contents of the foods or told what fat substitute is used in the preparation. (The consent form will state that a new fat-substitute may be used in the study foods.) During a "run-in" phase, olestra versus regular-fat food sensory and tolerance tests will be conducted.
Interventions
- BEHAVIORAL dietary education
- BEHAVIORAL dietary education and provided full fat snack foods
- BEHAVIORAL dietary education and provided fat free snack foods
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 1999-03 |
| Est. Completion | 2003-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00198965
The ClinicalTrials.gov registry entry for NCT00198965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which dietary education is the first listed.
NCT00198965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00198965 about?
NCT00198965 is a clinical study titled "Olestra Containing Foods and Weight Loss and Weight Maintenance". This study will be conducted over three phases. Phase I will be a 16-week weight lass phase. Phase II will be a 52-week maintenance phase. Phase III will be a follow-up phase. We will test three diet regimens: 1) an olestra group who will receive a weight-reducing diet that includes olestra-containi...
What is the current status of trial NCT00198965?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 1999-03. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00198965?
The interventions under investigation include: dietary education (BEHAVIORAL), dietary education and provided full fat snack foods (BEHAVIORAL), dietary education and provided fat free snack foods (BEHAVIORAL).
Who is sponsoring clinical trial NCT00198965?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.